DK1756086T3 - Pyridin-4-yl-ethynyl-imidazoler og pyrazoler som mglu5-receptorantagonister - Google Patents

Pyridin-4-yl-ethynyl-imidazoler og pyrazoler som mglu5-receptorantagonister

Info

Publication number
DK1756086T3
DK1756086T3 DK05744719T DK05744719T DK1756086T3 DK 1756086 T3 DK1756086 T3 DK 1756086T3 DK 05744719 T DK05744719 T DK 05744719T DK 05744719 T DK05744719 T DK 05744719T DK 1756086 T3 DK1756086 T3 DK 1756086T3
Authority
DK
Denmark
Prior art keywords
pyrazoles
imidazoles
ethynyl
pyridin
receptor antagonists
Prior art date
Application number
DK05744719T
Other languages
Danish (da)
English (en)
Inventor
Bernd Buettelmann
Georg Jaeschke
Sabine Kolczewski
Richard Hugh Philip Porter
Eric Vieira
Paul Spurr
Simona Maria Ceccarelli
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2004/005881 external-priority patent/WO2004108701A1/fr
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/EP2005/005559 external-priority patent/WO2005118568A1/fr
Application granted granted Critical
Publication of DK1756086T3 publication Critical patent/DK1756086T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK05744719T 2004-06-01 2005-05-23 Pyridin-4-yl-ethynyl-imidazoler og pyrazoler som mglu5-receptorantagonister DK1756086T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2004/005881 WO2004108701A1 (fr) 2003-06-05 2004-06-01 Derives d'imidazole utilises comme antagonistes du recepteur du glutamate
EP04021216 2004-09-07
PCT/EP2005/005559 WO2005118568A1 (fr) 2004-06-01 2005-05-23 Pyridin-4-yl-ethynyl-imidazoles et pyrazoles, antagonistes du recepteur mglur5

Publications (1)

Publication Number Publication Date
DK1756086T3 true DK1756086T3 (da) 2008-08-04

Family

ID=35758209

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05744719T DK1756086T3 (da) 2004-06-01 2005-05-23 Pyridin-4-yl-ethynyl-imidazoler og pyrazoler som mglu5-receptorantagonister

Country Status (20)

Country Link
US (2) US20060030559A1 (fr)
JP (1) JP4690395B2 (fr)
KR (2) KR100907108B1 (fr)
AR (1) AR054072A1 (fr)
AU (1) AU2005250101B2 (fr)
BR (1) BRPI0511678A (fr)
CA (1) CA2568725C (fr)
CR (1) CR8742A (fr)
CY (1) CY1108232T1 (fr)
DK (1) DK1756086T3 (fr)
EA (1) EA011722B1 (fr)
EC (1) ECSP067039A (fr)
ES (1) ES2307182T3 (fr)
HR (1) HRP20080363T3 (fr)
IL (1) IL179524A (fr)
MA (1) MA28602B1 (fr)
NZ (1) NZ551253A (fr)
PT (1) PT1756086E (fr)
SI (1) SI1756086T1 (fr)
TW (1) TWI297683B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329703B2 (en) * 2005-02-15 2012-12-11 Xtl Biopharmaceuticals Ltd. Pyrazole compounds
US8334287B2 (en) * 2009-07-17 2012-12-18 Hoffmann-La Roche Inc. Imidazoles
US20120039999A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120040008A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
JP7082484B2 (ja) 2015-04-01 2022-06-08 中外製薬株式会社 ポリペプチド異種多量体の製造方法
WO2017117708A1 (fr) 2016-01-05 2017-07-13 Hua Medicine (Shanghai) Ltd. Dérivés de pyrazole
ES2975136T3 (es) * 2016-03-30 2024-07-03 Sinntaxis AB Moduladores alost alostéricos negativos de MGLUR5 para uso en el tratamiento de daños cerebrales maduros
MX2022015407A (es) 2020-06-05 2023-05-16 Noema Pharma Ag Metodos de tratamiento del complejo de esclerosis tuberosa.
TWI924682B (zh) * 2020-07-30 2026-05-11 瑞士商諾埃瑪製藥公司 三叉神經痛之治療方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3033199A (en) * 1959-10-13 1962-05-08 Jacobs Clifford Roy Closure for protective device
US3045022A (en) 1960-04-07 1962-07-17 Reilly Tar & Chem Corp Process of preparing ethynylpyridines
US3303199A (en) 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
US3341548A (en) * 1964-04-29 1967-09-12 Hoffmann La Roche Nitroimidazoles and their preparation
DE2035905A1 (de) 1970-07-20 1972-02-03 Chemische Fabrik Stockhausen & Cie.,4150Krefeld Imidazolverbindungen und deren Herstellungsverfahren
CA1174673A (fr) 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
US4508560A (en) 1981-11-11 1985-04-02 Ciba Geigy Corporation Certain pyridylacetylene compounds, compositions containing same and herbicidal methods of use
US4711962A (en) * 1984-10-18 1987-12-08 Stauffer Chemical Company Process for selective preparation of ratios of isomers formed on N-substitution of asymmetric imidazoles
KR0163595B1 (ko) 1989-06-30 1998-12-01 미리암디, 메코너헤이 치환된 이미다졸
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
ID28529A (id) 1997-08-14 2001-05-31 Hoffmann La Roche Vinileter heterosiklik untuk gangguan neurologi
JP4815083B2 (ja) * 1999-08-31 2011-11-16 メルク・シャープ・エンド・ドーム・コーポレイション 複素環化合物およびそれの使用方法
AU779874B2 (en) 1999-10-15 2005-02-17 F. Hoffmann-La Roche Ag Benzodiazepine derivatives
IL136553A0 (en) 2000-06-05 2001-06-14 Compugen Ltd SPLICE VARIANT OF mGluR
JP5154728B2 (ja) 2000-07-24 2013-02-27 クレニツキー・ファーマシューティカルズ，インコーポレイテッド 神経栄養活性を有する置換５−アルキニルピリミジン
NZ525917A (en) * 2000-12-04 2005-11-25 F Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists and their use in treating mGLuR5 receptor mediated disorders
EP1238586A1 (fr) 2001-03-09 2002-09-11 Basf Aktiengesellschaft 2-alkynyl-pyri(mi)dines herbicides
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
CA2462289C (fr) 2001-10-04 2010-02-23 Nicholas D. Cosford Composes de tetrazole substitues par heteroaryle, modulateurs du recepteur-5 metabotropique du glutamate
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1458385A4 (fr) 2001-12-19 2005-12-21 Merck & Co Inc Imidazoles substitues par heteroaryle modulateurs du recepteur metabotropique du glutamate de type 5
JP2006513996A (ja) 2002-10-24 2006-04-27 メルク　エンド　カムパニー　インコーポレーテッド 代謝調節型グルタミン酸受容体結合用トレーサーとしてのアルキン誘導体
ITMI20030151A1 (it) 2003-01-30 2004-07-31 Recordati Ind Chimica E Farma Ceutica S P A Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore.
TWI292318B (en) * 2003-03-10 2008-01-11 Hoffmann La Roche Imidazol-4-yl-ethynyl-pyridine derivatives
US7531529B2 (en) 2003-06-05 2009-05-12 Roche Palo Alto Llc Imidazole derivatives
UA80888C2 (en) 2003-06-05 2007-11-12 Hoffmann La Roche Imidazole derivatives as glutmate receptor antagonists
US7091222B2 (en) * 2003-07-03 2006-08-15 Hoffmann-La Roche Inc. Imidazole derivatives
US7452909B2 (en) * 2003-09-04 2008-11-18 Hoffman-La Roche Inc. Imidazole derivatives
DE102004032567A1 (de) 2004-07-05 2006-03-02 Grünenthal GmbH Substituierte 1-Propiolyl-piperazine

Also Published As

Publication number Publication date
EA011722B1 (ru) 2009-04-28
KR20080089523A (ko) 2008-10-06
IL179524A (en) 2012-04-30
HRP20080363T3 (hr) 2008-09-30
JP4690395B2 (ja) 2011-06-01
KR20070021231A (ko) 2007-02-22
AU2005250101A1 (en) 2005-12-15
US20100048569A1 (en) 2010-02-25
AR054072A1 (es) 2007-06-06
CY1108232T1 (el) 2014-02-12
JP2008500979A (ja) 2008-01-17
EA200602154A1 (ru) 2007-06-29
MA28602B1 (fr) 2007-05-02
ECSP067039A (es) 2006-12-29
CA2568725C (fr) 2012-11-27
PT1756086E (pt) 2008-08-08
NZ551253A (en) 2010-07-30
US8293916B2 (en) 2012-10-23
TWI297683B (en) 2008-06-11
KR100907108B1 (ko) 2009-07-09
CA2568725A1 (fr) 2005-12-15
KR101057032B1 (ko) 2011-08-16
AU2005250101B2 (en) 2011-08-25
CR8742A (es) 2007-08-28
TW200609222A (en) 2006-03-16
US20060030559A1 (en) 2006-02-09
SI1756086T1 (sl) 2008-08-31
IL179524A0 (en) 2007-05-15
HK1105972A1 (zh) 2008-02-29
ES2307182T3 (es) 2008-11-16
BRPI0511678A (pt) 2008-01-08

Similar Documents

Publication Publication Date Title
DK1857457T3 (da) Benzimidazolderivat og dets anvendelse som All-receptor-antagonist
DK1951660T3 (da) Histamin-3-receptorantagonister
EP1790757A4 (fr) Compensateur
DK1720859T3 (da) Chemokinreceptorantagonister
DE602005023460D1 (de) Antimykotische polypeptide
DE602005025554D1 (de) Umfassendes Kommunikationssystem
ATE517886T1 (de) Pyrazolderivate
DK2200985T3 (da) 1,3-Disubstituerede 4-(aryl--X-phenyl)-1H-pyridin-2-oner
DK1711465T3 (da) Hydroisoindolin-tachykinikreceptorantagonister
NL1030324A1 (nl) Sulfonylbenzimidazoolderivaten.
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
ZA200609681B (en) Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mGlu5 receptor antagonists
ATE534628T1 (de) Urotensin ii-rezeptorantagonisten
IL176630A0 (en) Benzimidazole derivatives
DK2188268T3 (da) Substituerede piperazinylpyraziner og pyridiner som 5-HT7-receptorantagonister
IL179524A0 (en) Pyridin- 4 - yl - ethynyl - imidazoles and pyrazoles as mglu5 receptor antagonists
DE502004001207D1 (de) Schnellwechselbeschlag
ATE446292T1 (de) Heterocyclylamid-substituierte imidazole
DE112005002826A5 (de) Ausgleichseinheit
ATE425161T1 (de) Mercaptoimidazole als ccr2-rezeptorantagonisten
ATE411989T1 (de) Mercaptoimidazole als ccr2-rezeptorantagonisten
FI20040913L (fi) Punnituslaitteisto
ATA9962004A (de) Pleuelstange
GB0406137D0 (en) Substituted pyrazoles
FI20040905A0 (fi) Eristyselementti